Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant MYOD1 antibody (AA 1-100)

The Rabbit Monoclonal anti-MYOD1 antibody has been validated for IHC (f). It is suitable to detect MYOD1 in samples from Human.
Catalog No. ABIN7126737

Quick Overview for Recombinant MYOD1 antibody (AA 1-100) (ABIN7126737)

Target

See all MYOD1 Antibodies
MYOD1 (Myogenic Differentiation 1 (MYOD1))

Antibody Type

Recombinant Antibody

Reactivity

  • 147
  • 72
  • 66
  • 27
  • 2
Human

Host

  • 89
  • 62
  • 1
Rabbit

Clonality

  • 83
  • 69
  • 1
Monoclonal

Conjugate

  • 81
  • 9
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This MYOD1 antibody is un-conjugated

Application

  • 74
  • 44
  • 43
  • 43
  • 39
  • 21
  • 20
  • 18
  • 16
  • 16
  • 11
  • 9
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Binding Specificity

    • 16
    • 13
    • 9
    • 9
    • 7
    • 6
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-100

    Specificity

    MyoD1, one of the MyoD family of myogenic helix-loop-helix transcription factors, combined with myogenin, plays a role in coordinating the myogenic differentiation pathway from the determination of mesodermal precursors into myoblasts, the differentiation of myoblasts into myotubes, and finally the maturation of myotubes into skeletal myofibers. Normal mature skeletal muscle does not express MyoD1 protein. MyoD1 is expressed in myoblasts before differentiation while myogenin has post-differentiation functions. Anti-MyoD1 immunostaining identifies cells committed to myogenesis in their earliest phase, thus, it is a better biomarker for less differentiated Rhabdomyosarcomas (RMS). RMS are the most frequent malignant soft tissue neoplasms of childhood. While better differentiated RMS have cross-striations or rhabdomyoblasts that allow for a confident morphologic diagnosis, less differentiated RMS resemble other small blue round-cell tumors. Studies suggest, anti-MyoD1 may be used together with anti-Myogenin and anti-Desmin as a panel of markers since any RMS is virtually never negative for all three markers simultaneously.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment (around aa1-100) of human MyoD1 protein (exact sequence is proprietary)

    Isotype

    IgG
  • Application Notes

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human fetal skeletal muscle or rhabdomyosarcoma.

    Restrictions

    For Research Use only
  • Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    MYOD1 (Myogenic Differentiation 1 (MYOD1))

    Alternative Name

    MYOD1

    Background

    BHLHc1, Class C basic helix-loop-helix protein 1, Myoblast determination protein 1, Myogenic differentiation 1, Myogenic factor 3 (Myf-3), Myogenin D1, PUM,MyoD1 (Rhabdomyosarcoma Marker)
    Cellular localisation: Nuclear

    Molecular Weight

    45kDa

    Gene ID

    4654, 181768

    UniProt

    P15172

    Pathways

    Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
You are here:
Chat with us!